Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized Controlled Trial of Preoperative Sequential Short-course Radiation Therapy and Oxaliplatin-based Consolidation Chemotherapy for Locally Advanced Rectal Cancer
The treatment protocol proposed in this study is to perform short-term radiation therapy and 4 cycles of FOLFOX chemotherapy for neoadjuvant treatment of locally advanced rectal cancer. Compared to conventional chemoradiation therapy, the preoperative radiotherapy period is shortened, and the cure rate of rectal cancer patients can be improved by early treatment of micrometastasis using systemic chemotherapy. The patients who are assigned to the study group will received the short-course radiotherapy and 4 cycles of FOLFOX and patients in the control will received conventional chemoradiotherapy for preoperative treatment. All patients are recommended to receive total mesorectal excision (TME) after neoadjuvant treatment and adjuvant chemotherapy will be given according to the pathological stage.
Age
20 - 75 years
Sex
ALL
Healthy Volunteers
No
Gyu seog Choi
Daegu, South Korea
Chungnam National University Hospital
Daejeon, South Korea
Chonnam National University Hwasun Hospital
Gwangju, South Korea
Catholic University of Korea Incheon St. Mary's Hospital
Incheon, South Korea
Jeonbuk National University Hospital
Jeonju, South Korea
Asan Medical Center
Seoul, South Korea
, Korea University Anam Hospital
Seoul, South Korea
Gangnam Severance Hospital
Seoul, South Korea
Seoul National University Bundang Hospital
Seoul, South Korea
Start Date
October 23, 2020
Primary Completion Date
December 28, 2028
Completion Date
December 28, 2031
Last Updated
February 12, 2026
364
ESTIMATED participants
short-course radiotherapy
RADIATION
mFOLFOX6
DRUG
Chemoradiotherapy
RADIATION
TME surgery
PROCEDURE
Lead Sponsor
Kyungpook National University Hospital
Collaborators
NCT04704661
NCT06696768
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions